AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 251 filers reported holding AVANOS MED INC in Q3 2023. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532 | +288.3% | 26,306 | +391.1% | 0.01% | +500.0% |
| Q2 2023 | $137 | -99.9% | 5,357 | -13.9% | 0.00% | -50.0% |
| Q3 2022 | $136,000 | -71.5% | 6,225 | -64.4% | 0.00% | -60.0% |
| Q2 2022 | $478,000 | -89.6% | 17,476 | -86.8% | 0.01% | -80.0% |
| Q4 2021 | $4,595,000 | +178.8% | 132,523 | +150.9% | 0.02% | +212.5% |
| Q3 2021 | $1,648,000 | +1500.0% | 52,818 | +1769.0% | 0.01% | – |
| Q2 2021 | $103,000 | -83.3% | 2,826 | -79.9% | 0.00% | -100.0% |
| Q1 2021 | $616,000 | +38.4% | 14,075 | +45.1% | 0.00% | +50.0% |
| Q4 2020 | $445,000 | -61.1% | 9,698 | -75.1% | 0.00% | -80.0% |
| Q2 2020 | $1,143,000 | +294.1% | 38,883 | +261.4% | 0.01% | +233.3% |
| Q1 2020 | $290,000 | -2.7% | 10,759 | +21.6% | 0.00% | 0.0% |
| Q4 2019 | $298,000 | -39.7% | 8,847 | -32.9% | 0.00% | -25.0% |
| Q3 2019 | $494,000 | -77.4% | 13,194 | -73.6% | 0.00% | -73.3% |
| Q2 2019 | $2,182,000 | +116.5% | 50,040 | +111.9% | 0.02% | +66.7% |
| Q1 2019 | $1,008,000 | -55.8% | 23,615 | -53.6% | 0.01% | -55.0% |
| Q4 2018 | $2,281,000 | +8.6% | 50,933 | +66.0% | 0.02% | +25.0% |
| Q3 2018 | $2,101,000 | – | 30,674 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |